Imprimis Pharmaceuticals Inc (IMMY.OQ)

IMMY.OQ on NASDAQ Stock Exchange Capital Market

8.60USD
31 Oct 2014
Price Change (% chg)

$-0.11 (-1.26%)
Prev Close
$8.71
Open
$8.75
Day's High
$8.80
Day's Low
$8.60
Volume
2,440
Avg. Vol
7,447
52-wk High
$9.44
52-wk Low
$3.01

IMMY.OQ

Chart for IMMY.OQ

About

Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company’s Transdel cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel, the Company’s lead pain product,... (more)
No analyst recommendations are available for IMMY.OQ.

Overall

Beta: -1.32
Market Cap (Mil.): $78.52
Shares Outstanding (Mil.): 9.13
Dividend: --
Yield (%): --

Financials

  IMMY.OQ Industry Sector
P/E (TTM): -- 161.49 34.61
EPS (TTM): -0.98 -- --
ROI: -59.59 -1.81 17.29
ROE: -60.59 -7.61 18.12
Search Stocks

Competitors

  Price Change
Eli Lilly and Co (LLY.N) $66.33 -0.47
Sanofi SA (SASY.PA) €73.66 +1.75
Bayer AG (BAYGn.DE) €95.41 -2.28
Bayer AG (BAYE.F) -- --
Roche Holding Ltd. (ROG.VX) CHF283.70 +0.30
Merck & Co., Inc. (MRK.N) $57.94 +0.63
Novartis AG (NOVN.VX) CHF89.30 +1.60

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: TheStreet.com Ratings
$10.00
Provider: TheStreet.com Ratings
$10.00
Provider: TheStreet.com Ratings
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks